Brief: Crescita To Receive One-Time Cash Payment Following Amendment To Pliaglis U.S. Licensing Agreement
28/07/2020 12:42
July 28 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA TO RECEIVE ONE-TIME CASH PAYMENT FOLLOWING
AMENDMENT TO
PLIAGLIS® U.S. LICENSING AGREEMENT
* CRESCITA THERAPEUTICS - ENTERED INTO AN AMENDMENT TO
DEVELOPMENT
AND COMMERCIALIZATION AGREEMENT WITH TARO PHARMACEUTICALS
* CRESCITA THERAPEUTICS INC - AMENDMENT ENTITLES CRESCITA TO
RECEIVE A ONE-TIME PAYMENT OF US$3.9 MILLION
Source text for Eikon: ID:nPnFRHH6a
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium